Targeted long-read sequencing allows for rapid identification of pathogenic disease-causing variants in retinoblastoma

References

• Stacey AW, Bowman R, Foster A, Kivelä TT, Munier FL, Cassoux N, Fabian ID, Harby LA, Portabella SA, Alia DB, et al. Incidence of incidence of retinoblastoma has increased: results from 40 european countries. Ophthalmology. 2021;128(9):1369–71. doi:10.1016/j.ophtha.2021.01.024.
   PubMed Web of Science ®Google Scholar
• Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, Abramson DH, Shields CL, Chantada GL, Njuguna F, et al. Retinoblastoma. Nat Rev Dis Primers. 2015;1(1):15021. doi:10.1038/nrdp.2015.21.
   PubMedGoogle Scholar
• Hong FD, Huang HJ, To H, Young LJ, Oro A, Bookstein R, Lee EY, Lee WH. Structure of the human retinoblastoma gene. Proc Natl Acad Sci USA. 1989;86(14):5502–06. doi:10.1073/pnas.86.14.5502.
   PubMed Web of Science ®Google Scholar
• Zhang J, Benavente CA, McEvoy J, Flores-Otero J, Ding L, Chen X, Ulyanov A, Wu G, Wilson M, Wang J, et al. A novel retinoblastoma therapy from genomic and epigenetic analyses. Nature. 2012;481(7381):329–34. doi:10.1038/nature10733.
   PubMed Web of Science ®Google Scholar
• Kooi IE, Mol BM, Massink MPG, Ameziane N, Meijers-Heijboer H, Dommering CJ, van Mil SE, de Vries Y, van der Hout AH, Kaspers GJL, et al. Somatic genomic alterations in retinoblastoma beyond RB1 are rare and limited to copy number changes. Sci Rep. 2016;6(1):25264. doi:10.1038/srep25264.
   PubMed Web of Science ®Google Scholar
• Kleinerman RA, Yu C-L, Little MP, Li Y, Abramson D, Seddon J, Tucker MA. Variation of second cancer risk by family history of retinoblastoma among long-term survivors. J Clin Oncol. 2012;30(9):950–57. doi:10.1200/JCO.2011.37.0239.
   PubMed Web of Science ®Google Scholar
• Fabian ID, Abdallah E, Abdullahi SU, Abdulqader RA, Adamou Boubacar S, Ademola-Popoola DS, Adio A, Afshar AR, Aggarwal P, Aghaji AE, et al. Global retinoblastoma presentation and analysis by national income level. JAMA Oncol. 2020;6(5):685–95. doi:10.1001/jamaoncol.2019.6716.
   PubMed Web of Science ®Google Scholar
• Ancona-Lezama D, Dalvin LA, Shields CL. Modern treatment of retinoblastoma: a 2020 review. Indian J Ophthalmol. 2020;68(11):2356–65. doi:10.4103/ijo.IJO_721_20.
   PubMed Web of Science ®Google Scholar
• Fernandes AG, Pollock BD, Rabito FA. Retinoblastoma in the United States: a 40-year incidence and survival analysis. J Pediatr Ophthalmol Strabismus. 2018;55(3):182–88. doi:10.3928/01913913-20171116-03.
   PubMed Web of Science ®Google Scholar
• Gröbner SN, Worst BC, Weischenfeldt J, Buchhalter I, Kleinheinz K, Rudneva VA, Johann PD, Balasubramanian GP, Segura-Wang M, Brabetz S, et al. The landscape of genomic alterations across childhood cancers. Nature. 2018;555(7696):321–27. doi:10.1038/nature25480.
   PubMed Web of Science ®Google Scholar
• Mallipatna A, Marino M, Singh AD. Genetics of retinoblastoma. Asia Pac J Ophthalmol (Phila). 2016;5(4):260–64. doi:10.1097/APO.0000000000000219.
   PubMed Web of Science ®Google Scholar
• Friend SH, Bernards R, Rogelj S, Weinberg RA, Rapaport JM, Albert DM, Dryja TP. A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 1986;323(6089):643–46. doi:10.1038/323643a0.
   PubMed Web of Science ®Google Scholar
• Kline CN, Joseph NM, Grenert JP, van Ziffle J, Talevich E, Onodera C, Aboian M, Cha S, Raleigh DR, Braunstein S, et al. Targeted next-generation sequencing of pediatric neuro-oncology patients improves diagnosis, identifies pathogenic germline mutations, and directs targeted therapy. Neuro Oncol. 2017;19(5):699–709. doi:10.1093/neuonc/now254.
   PubMed Web of Science ®Google Scholar
• Cheng DT, Mitchell TN, Zehir A, Shah RH, Benayed R, Syed A, Chandramohan R, Liu ZY, Won HH, Scott SN, et al. Memorial sloan kettering-integrated mutation profiling of actionable cancer targets (MSK-IMPACT): a hybridization capture-based next-generation sequencing clinical assay for solid tumor molecular oncology. J Mol Diagn. 2015;17(3):251–64. doi:10.1016/j.jmoldx.2014.12.006.
   PubMed Web of Science ®Google Scholar
• Davies HR, Broad KD, Onadim Z, Price EA, Zou X, Sheriff I, Karaa EK, Scheimberg I, Reddy MA, Sagoo MS, et al. Whole-genome sequencing of retinoblastoma reveals the diversity of rearrangements disrupting rb1 and uncovers a treatment-related mutational signature. Cancers. 2021;13(4):754. doi:10.3390/cancers13040754.
   PubMed Web of Science ®Google Scholar
• Francis JH, Richards AL, Mandelker DL, Berger MF, Walsh MF, Dunkel IJ, Donoghue MTA, Abramson DH. Molecular changes in retinoblastoma beyond RB1: findings from next-generation sequencing. Cancers. 2021;13(1):149. doi:10.3390/cancers13010149.
   PubMed Web of Science ®Google Scholar
• Afshar AR, Pekmezci M, Bloomer MM, Cadenas NJ, Stevers M, Banerjee A, Roy R, Olshen AB, Van Ziffle J, Onodera C, et al. Next-generation sequencing of retinoblastoma identifies pathogenic alterations beyond RB1 inactivation that correlate with aggressive histopathologic features. Ophthalmology. 2020;127(6):804–13. doi:10.1016/j.ophtha.2019.12.005.
   PubMed Web of Science ®Google Scholar
• Vilfan ID, Tsai Y-C, Clark TA, Wegener J, Dai Q, Yi C, Pan T, Turner SW, Korlach J. Analysis of RNA base modification and structural rearrangement by single-molecule real-time detection of reverse transcription. J Nanobiotechnol. 2013;11(1):8. doi:10.1186/1477-3155-11-8.
   PubMedGoogle Scholar
• Rand AC, Jain M, Eizenga JM, Musselman-Brown A, Olsen HE, Akeson M, Paten B. Mapping DNA methylation with high-throughput nanopore sequencing. Nat Methods. 2017;14(4):411–13. doi:10.1038/nmeth.4189.
   PubMed Web of Science ®Google Scholar
• Simpson JT, Workman RE, Zuzarte PC, David M, Dursi LJ, Timp W. Detecting DNA cytosine methylation using nanopore sequencing. Nat Methods. 2017;14(4):407–10. doi:10.1038/nmeth.4184.
   PubMed Web of Science ®Google Scholar
• Gelli E, Pinto AM, Somma S, Imperatore V, Cannone MG, Hadjistilianou T, De Francesco S, Galimberti D, Currò A, Bruttini M, et al. Evidence of predisposing epimutation in retinoblastoma. Hum Mutat. 2019;40(2):201–06. doi:10.1002/humu.23684.
   PubMed Web of Science ®Google Scholar
• Quiñonez-Silva G, Dávalos-Salas M, Recillas-Targa F, Ostrosky-Wegman P, Aranda DA, Benítez-Bribiesca L. Monoallelic germline methylation and sequence variant in the promoter of the RB1 gene: a possible constitutive epimutation in hereditary retinoblastoma. Clin Epigenetics. 2016;8(1):1. doi:10.1186/s13148-015-0167-0.
   PubMedGoogle Scholar
• Li H-T, Xu L, Weisenberger DJ, Li M, Zhou W, Peng C-C, Stachelek K, Cobrinik D, Liang G, Berry JL. Characterizing DNA methylation signatures of retinoblastoma using aqueous humor liquid biopsy. Nat Commun. 2022;13(1):5523. doi:10.1038/s41467-022-33248-2.
   PubMed Web of Science ®Google Scholar
• Shafin K, Pesout T, Chang P-C, Nattestad M, Kolesnikov A, Goel S, Baid G, Kolmogorov M, Eizenga JM, Miga KH, et al. Haplotype-aware variant calling with PEPPER-margin-DeepVariant enables high accuracy in nanopore long-reads. Nat Methods. 2021;18(11):1322–32. doi:10.1038/s41592-021-01299-w.
   PubMed Web of Science ®Google Scholar
• Loose M, Malla S, Stout M. Real-time selective sequencing using nanopore technology. Nat Methods. 2016;13(9):751–54. doi:10.1038/nmeth.3930.
   PubMed Web of Science ®Google Scholar
• Payne A, Holmes N, Clarke T, Munro R, Debebe BJ, Loose M. Readfish enables targeted nanopore sequencing of gigabase-sized genomes. Nat Biotechnol. 2021;39(4):442–50. doi:10.1038/s41587-020-00746-x.
   PubMed Web of Science ®Google Scholar
• Li H, Durbin R. Fast and accurate short read alignment with Burrows-Wheeler transform. Bioinformatics. 2009;25(14):1754–60. doi:10.1093/bioinformatics/btp324.
   PubMed Web of Science ®Google Scholar
• Poplin R, Ruano-Rubio V, DePristo MA, Fennell TJ, Carneiro MO, Van der Auwera GA, Kling DE, Gauthier LD, Levy-Moonshine A, Roazen D, et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv. 201178. [accessed 2018 July 24]. doi:10.1101/201178.
   Google Scholar
• Li H, Birol I. Minimap2: pairwise alignment for nucleotide sequences. Bioinformatics. 2018;34(18):3094–100. doi:10.1093/bioinformatics/bty191.
   PubMed Web of Science ®Google Scholar
• Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46(3):310–15. doi:10.1038/ng.2892.
   PubMed Web of Science ®Google Scholar
• Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res. 2019;47(D1):D886–94. doi:10.1093/nar/gky1016.
   PubMed Web of Science ®Google Scholar
• Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the american college of medical genetics and genomics and the association for molecular pathology. Genet Med. 2015;17(5):405–23. doi:10.1038/gim.2015.30.
   PubMed Web of Science ®Google Scholar
• Auton A, Brooks LD, Durbin RM, Garrison EP, Kang HM, Korbel JO, Marchini JL, McCarthy S, McVean GA, Eichler EE, et al. A global reference for human genetic variation. Nature. 2015;526(7571):68–74. doi:10.1038/nature15393.
   PubMed Web of Science ®Google Scholar
• Li W, Freudenberg J. Mappability and read length. Front Genet. 2014;5:381. doi:10.3389/fgene.2014.00381.
   PubMed Web of Science ®Google Scholar
• Stancu MC, Van Roosmalen MJ, Renkens I, Nieboer MM, Middelkamp S, De Ligt J, Pregno G, Giachino D, Mandrile G, Valle-Inclan JE, et al. Mapping and phasing of structural variation in patient genomes using nanopore sequencing. Nat Commun. 2017;8(1):1–13. doi:10.1038/s41467-017-01343-4.
   PubMedGoogle Scholar
• Delahaye C, Nicolas J, Andrés-León E. Sequencing DNA with nanopores: troubles and biases. Plos One. 2021;16(10):e0257521. doi:10.1371/journal.pone.0257521.
   PubMed Web of Science ®Google Scholar
• Lee WH, Murphree AL, Benedict WF. Expression and amplification of the N-myc gene in primary retinoblastoma. Nature. 1984;309(5967):458–60. doi:10.1038/309458a0.
   PubMed Web of Science ®Google Scholar
• Rushlow DE, Mol BM, Kennett JY, Yee S, Pajovic S, Thériault BL, Prigoda-Lee NL, Spencer C, Dimaras H, Corson TW, et al. Characterisation of retinoblastomas without RB1 mutations: genomic, gene expression, and clinical studies. Lancet Oncol. 2013;14(4):327–34. doi:10.1016/S1470-2045(13)70045-7.
   PubMed Web of Science ®Google Scholar
• Kim ME, Polski A, Xu L, Prabakar RK, Peng C-C, Reid MW, Shah R, Kuhn P, Cobrinik D, Hicks J, et al. Comprehensive somatic copy number analysis using aqueous humor liquid biopsy for retinoblastoma. Cancers. 2021;13(13):3340. doi:10.3390/cancers13133340.
   PubMed Web of Science ®Google Scholar
• Berry JL, Xu L, Murphree AL, Krishnan S, Stachelek K, Zolfaghari E, McGovern K, Lee TC, Carlsson A, Kuhn P, et al. Potential of aqueous humor as a surrogate tumor biopsy for retinoblastoma. JAMA Ophthalmol. 2017;135(11):1221–30. doi:10.1001/jamaophthalmol.2017.4097.
   PubMed Web of Science ®Google Scholar
• Xu L, Shen L, Polski A, Prabakar RK, Shah R, Jubran R, Kim JW, Biegel J, Kuhn P, Cobrinik D, et al. Simultaneous identification of clinically relevant RB1 mutations and copy number alterations in aqueous humor of retinoblastoma eyes. Ophthalmic Genet. 2020;41(6):526–32. doi:10.1080/13816810.2020.1799417.
   PubMed Web of Science ®Google Scholar
• Polski A, Xu L, Prabakar RK, Kim JW, Shah R, Jubran R, Kuhn P, Cobrinik D, Hicks J, Berry JL. Cell-free DNA tumor fraction in the aqueous humor is associated with therapeutic response in retinoblastoma Patients. Transl Vis Sci Technol. 2020;9(10):30. doi:10.1167/tvst.9.10.30.
   PubMed Web of Science ®Google Scholar
• Marcozzi A, Jager M, Elferink M, Straver R, van Ginkel JH, Peltenburg B, Chen L-T, Renkens I, van Kuik J, Terhaard C, et al. Accurate detection of circulating tumor DNA using nanopore consensus sequencing. NPJ Genom Med. 2021;6(1):106. doi:10.1038/s41525-021-00272-y.
   PubMed Web of Science ®Google Scholar
• Quick J, Loman NJ, Duraffour S, Simpson JT, Severi E, Cowley L, Bore JA, Koundouno R, Dudas G, Mikhail A, et al. Real-time, portable genome sequencing for ebola surveillance. Nature. 2016;530(7589):228–32. doi:10.1038/nature16996.
   PubMed Web of Science ®Google Scholar
• Gorzynski JE, Goenka SD, Shafin K, Jensen TD, Fisk DG, Grove ME, Spiteri E, Pesout T, Monlong J, Baid G, et al. Ultrarapid nanopore genome sequencing in a critical care setting. N Engl J Med. 2022;386(7):700–02. [accessed 2022 Jan 12]. doi:10.1056/NEJMc2112090.
   PubMed Web of Science ®Google Scholar
• Norrie JL, Nityanandam A, Lai K, Chen X, Wilson M, Stewart E, Griffiths L, Jin H, Wu G, Orr B, et al. Retinoblastoma from human stem cell-derived retinal organoids. Nat Commun. 2021;12(1):4535. doi:10.1038/s41467-021-24781-7.
   PubMed Web of Science ®Google Scholar